In addition to modulating PCC-autonomous actions, and cancer-associated inflammatory signaling, our findings suggest that STAT3 acts in ECs to promote tumor angiogenesis, and facilitate angiocrine actions. This evidence concerns the gene STAT3 and neoplasm.